课题基金 / 基金详情

Regulation of adhesion molecule integrins by membrane-bound proteinase ADAM

Regulation of adhesion molecule integrins by membrane-bound proteinase ADAM
膜结合蛋白酶 ADAM 对粘附分子整合素的调节
批准号:
16390117
负责人:
MATSUURA Nariaki
金额:
$9.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

MATSUURA Nariaki的其他基金

相似基金

相关文献

中文摘要
翻译
ADAM是由金属蛋白酶和去整合素组成的膜结合分子。为了阐明ADAM分子在肺癌细胞EBC-1脑转移亚系和骨转移亚系中的表达,探讨ADAM分子在肺癌转移中的作用。结果表明,ADAM9在脑转移亚系中的表达水平明显高于骨转移亚系或亲本细胞系。将ADAM9基因转入Kung癌A549细胞,可增加NGF刺激的侵袭活性,增加对脑组织切片的粘附力,上调整合素a3b1的表达。转染组和亲本细胞系在其他整合素表达水平上无明显差异。当通过尾静脉接种到滑行小鼠的尾静脉时,转染体诱导了大量肺和脑转移。另一方面,亲本细胞或模拟转染体诱导了大量的肺转移,但没有引起脑转移。将ADAM9基因导入HT1080纤维肉瘤HT1080细胞,流式细胞仪分析表明,只有整合素A4在转染体中消失,而亲本细胞或模型细胞表达整合素A4。转基因细胞与整合素a4b1的配体CS-1多肽或血管细胞黏附分子-1(VCAM-1)的粘附性降低。对CS-1或VCAM-1的迁移或侵袭活性也降低。将亲本细胞接种于裸小鼠尾静脉,可诱导大量肺转移,但转染者肺转移明显减少。皮下注射后肿瘤组织中ADAM9的表达无明显差异,提示ADAM9可能在整合素表达及肿瘤转移中起一定作用。
英文摘要
ADAM is membrane-bound molecules composed of metalloproteinase and disintegrin. Expression of ADAM molecules of highly brain-metastatic subline and bone-metastatic subline from lung cancer cell EBC-1 cells are studied in order to clarify the implication of ADAM in cancer metastasis. As a result the expression level of ADAM9 mRNA was upregulated in brain-metastatic subline than those in bone-metastatic subline or parental cell line. Transfection of ADAM9 cDNA in kung cancer A549 cell resulted in increased NGF-stimulated invasive activity, elevated adhesion to brain tissue slices and upregulation of integrin a3b1 expression. There were no differences between transfectant and parental cell line in other integrin expression levels. When inoculated intravenously to the tail vein in skid mice, transfectants induced numerous lung and brain metastases. On the other hand parental cells or mock transfectant induced plenty of lung metastases, but not brain metastasis. These results suggested ADAM9 might play a role in brain metastasis of lung cancer.Transfection of ADAM9 cDNA in fibrosarcoma HT1080 cell was preformed and FACS analysis of each integrin expression showed disappearance of only integrin a4 in transfectants while parental cell or mock transfectant expressed integrin a4. Decreased adhesion of transfectants to CS-1 peptide or VCAM-1 (vascular cell adhesion molecule-1), both of which are ligands of integrin a4b1, was observed. Migratory or invasive activity to CS-1 or VCAM-1 was also reduced. When inoculated intravenously to tail vein of nude mice, parent cells induced a number of lung metastases but marked decreased lung metastases were found in transfectants. There were no differences in the tumor after subcutaneous injection.These data suggested ADAM9 might play some roles in integrin expression and also in cancer metastasis.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1078-0432.ccr-05-1213
发表时间: 2006-08-01
期刊: CLINICAL CANCER RESEARCH
影响因子: 11.5
作者: [Yasui, Masayoshi, Yamamoto, Hirofumi, Monden, Morito]
通讯作者: Monden, Morito
Methylation and expression p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
原发性结直肠癌组织中p16INK4抑癌基因的甲基化及表达。
DOI: --
发表时间: 2005
期刊: Int J Oncol 26・5
影响因子: --
作者: [Kim BN, Matsuura N, et al.]
通讯作者: et al.
肝転移のすべて
关于肝转移的一切
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [松浦成昭, 横山雄起, 他, 門田守人]
通讯作者: 門田守人
ADAM-binding protein Eve-1 is required for ectodomain shedding of EGF receptor ligands
ADAM 结合蛋白 Eve-1 是 EGF 受体配体胞外域脱落所必需的
DOI: --
发表时间: 2004
期刊: J.Biol.Chem. 279
影响因子: --
作者: [Tanaka, M.et al.]
通讯作者: M.et al.
共 18 条
    Novel angiogenesis inhibitor DBP-maf for cancer therapy
    • 批准号:
      23659611
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MATSUURA Nariaki
    • 依托单位:
    Application of integrin α4β1 for diagnosis and therapy of bone metastasis
    • 批准号:
      10670158
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      1998
    • 负责人:
      MATSUURA Nariaki
    • 依托单位:
    Study on the role of integrin alpha4beta1 in bone metastasis
    国内基金
    海外基金
    血管衰老通过lumican-integrinα2β1通路诱导NVU调控认知障碍的分子机制及干预靶点研究
    • 批准号:
      JCZRLH202602095
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
    • 批准号:
      JCZRLH202600554
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    睡眠剥夺经TNN/Integrin α8β1轴调控巨噬细胞极化促动脉粥样硬化的作用及机制研究
    • 批准号:
      2025JJ60778
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      高嘉慧
    • 依托单位:
    维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究